201 related articles for article (PubMed ID: 15136506)
1. Chronic hyperglycemia attenuates coronary collateral development and impairs proliferative properties of myocardial interstitial fluid by production of angiostatin.
Weihrauch D; Lohr NL; Mraovic B; Ludwig LM; Chilian WM; Pagel PS; Warltier DC; Kersten JR
Circulation; 2004 May; 109(19):2343-8. PubMed ID: 15136506
[TBL] [Abstract][Full Text] [Related]
2. The possible mechanism for impaired angiogenesis after transient focal ischemia in type 2 diabetic GK rats: different expressions of angiostatin and vascular endothelial growth factor.
Zhu M; Bi X; Jia Q; Shangguan S
Biomed Pharmacother; 2010 Mar; 64(3):208-13. PubMed ID: 19932587
[TBL] [Abstract][Full Text] [Related]
3. Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide.
Matsunaga T; Weihrauch DW; Moniz MC; Tessmer J; Warltier DC; Chilian WM
Circulation; 2002 May; 105(18):2185-91. PubMed ID: 11994253
[TBL] [Abstract][Full Text] [Related]
4. Temporal expression of extracellular matrix metalloproteinases and tissue plasminogen activator in the development of collateral vessels in the canine model of coronary occlusion.
Tyagi SC; Kumar S; Cassatt S; Parker JL
Can J Physiol Pharmacol; 1996 Aug; 74(8):983-95. PubMed ID: 8960389
[TBL] [Abstract][Full Text] [Related]
5. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in human type 2 diabetic arterial vasculature.
Chung AW; Hsiang YN; Matzke LA; McManus BM; van Breemen C; Okon EB
Circ Res; 2006 Jul; 99(2):140-8. PubMed ID: 16778129
[TBL] [Abstract][Full Text] [Related]
7. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
8. Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.
Pozzi A; LeVine WF; Gardner HA
Oncogene; 2002 Jan; 21(2):272-81. PubMed ID: 11803470
[TBL] [Abstract][Full Text] [Related]
9. [Effects of tissue inhibitor-3 of matrix metalloproteinases gene-transfected vascular smooth muscle cells transplantation on initial myocardium remodeling after acute myocardial infarction].
Jia Z; Tian H; Liu K
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 May; 21(5):512-6. PubMed ID: 17578293
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species are critical mediators of coronary collateral development in a canine model.
Gu W; Weihrauch D; Tanaka K; Tessmer JP; Pagel PS; Kersten JR; Chilian WM; Warltier DC
Am J Physiol Heart Circ Physiol; 2003 Oct; 285(4):H1582-9. PubMed ID: 12816750
[TBL] [Abstract][Full Text] [Related]
11. Intermittent high glucose enhances proliferation of vascular smooth muscle cells by upregulating osteopontin.
Sun J; Xu Y; Dai Z; Sun Y
Mol Cell Endocrinol; 2009 Dec; 313(1-2):64-9. PubMed ID: 19723557
[TBL] [Abstract][Full Text] [Related]
12. Bradycardia stimulates vascular growth during gradual coronary occlusion.
Lamping KG; Zheng W; Xing D; Christensen LP; Martins J; Tomanek RJ
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2122-7. PubMed ID: 16051883
[TBL] [Abstract][Full Text] [Related]
13. Progesterone induces human leukocyte antigen-g expression in vascular endothelial and smooth muscle cells.
Sheshgiri R; Rao V; Tumiati LC; Xiao R; Prodger JL; Badiwala M; Librach C; Delgado DH
Circulation; 2008 Sep; 118(14 Suppl):S58-64. PubMed ID: 18824770
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor is required for coronary collateral growth in the rat.
Toyota E; Warltier DC; Brock T; Ritman E; Kolz C; O'Malley P; Rocic P; Focardi M; Chilian WM
Circulation; 2005 Oct; 112(14):2108-13. PubMed ID: 16203926
[TBL] [Abstract][Full Text] [Related]
15. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide.
Matsunaga T; Warltier DC; Weihrauch DW; Moniz M; Tessmer J; Chilian WM
Circulation; 2000 Dec; 102(25):3098-103. PubMed ID: 11120701
[TBL] [Abstract][Full Text] [Related]
16. Repetitive coronary artery occlusions induce release of growth factors into the myocardial interstitium.
Weihrauch D; Tessmer J; Warltier DC; Chilian WM
Am J Physiol; 1998 Sep; 275(3):H969-76. PubMed ID: 9724302
[TBL] [Abstract][Full Text] [Related]
17. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells.
Oak MH; El Bedoui J; Anglard P; Schini-Kerth VB
Circulation; 2004 Sep; 110(13):1861-7. PubMed ID: 15364805
[TBL] [Abstract][Full Text] [Related]
18. Angiostatin is negatively associated with coronary collateral growth in patients with coronary artery disease.
Matsunaga T; Chilian WM; March K
Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2042-6. PubMed ID: 15840902
[TBL] [Abstract][Full Text] [Related]
19. Hypercholesterolemia impairs the myocardial angiogenic response in a swine model of chronic ischemia: role of endostatin and oxidative stress.
Boodhwani M; Nakai Y; Mieno S; Voisine P; Bianchi C; Araujo EG; Feng J; Michael K; Li J; Sellke FW
Ann Thorac Surg; 2006 Feb; 81(2):634-41. PubMed ID: 16427865
[TBL] [Abstract][Full Text] [Related]
20. An automated coronary artery occlusion device for stimulating collateral development in vivo.
Rys R; LaDisa JF; Tessmer JP; Gu W; Kersten JR; Warltier DC; Pagel PS
J Pharmacol Toxicol Methods; 2002; 48(2):111-8. PubMed ID: 14565568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
